Reuters logo
BRIEF-Valeant Pharma CFO Paul Herendeen reports open market purchase of co's shares
March 16, 2017 / 9:46 PM / 7 months ago

BRIEF-Valeant Pharma CFO Paul Herendeen reports open market purchase of co's shares

March 16 (Reuters) - Valeant Pharmaceuticals International Inc

* Valeant pharmaceuticals-cfo paul herendeen reports open market purchase of 24,000 shares of co’s common stock at average price of $10.72per share on march 14 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below